1<!DOCTYPE html>
2
3Anonymous
4/bestp
5/bestp/domrep.nsf
6244F3B43FC83630965258296001BAA9E
8
9
10
11
12
13
140
15
16
17/bestp/domrep.nsf/products/db-strategies-developing-strong-field-based-medical-teams-cardiovascular-diabetes?opendocument
18
19opendocument
2018.204.48.199
21
22
23www.best-in-class.com
24/bestp/domrep.nsf
25DB




Products & Services Medical Affairs Medical Science Liaison

Strategies for Developing Strong Field-Based Medical Teams in Cardiovascular and Diabetes

ID: 5513


Features:

6 Info Graphics

25 Data Graphics

480+ Metrics


Pages/Slides: 43


Published: 2018


Delivery Format: Online PDF Document


 

License Options:
close

Single User: Authorizes use by the person who places the order or for whom the order was placed.

Sitewide: Authorizes use of the report for a geographic site. All people at site can view the report for a year and copies can be printed.

Corporate: Authorizes use for the entire company for a year and copies can be printed. No limitations for usage inside the company.




Buy Now

 


  • STUDY OVERVIEW
  • BENCHMARK CLASS
  • SPECIAL OFFER
Non-members: Click here to review a complimentary excerpt from “Strategies for Developing Strong Field-Based Medical Teams in Cardiovascular and Diabetes”


STUDY OVERVIEW



Field-based medical teams play an important role in developing and maintaining relationships with key stakeholders such as physicians, payers and KOLs. However, it is critical to have defined roles and responsibilities for each of the different liaison types within the field-based medical team to enhance customer engagement and to avoid overlapping communications to the same stakeholders.

Moreover, field-based medical teams that focus on the cardiovascular and/or diabetes therapeutic areas need focused strategies and optimal resources to meet the growing information needs of stakeholders in these therapeutic areas.

Best Practices, LLC conducted this benchmarking study to highlight the winning strategies utilized by leading pharmaceutical and biotechnology companies to develop robust field-based medical teams, especially in support of new treatments in the cardiovascular and diabetes therapeutic areas. This study delivers benchmarks into the deployment of Medical Science Liaisons (MSLs) and
Health Outcomes Liaisons (HOLs), including the value associated with field-based team responsibilities, time allocation for key activities, key performance indicators, thought leader visit frequency, FTE allocation, staffing and training trends.

KEY TOPICS


1. Field-Based Medical Team Activities

  • Actual time spent on key activities vs. expected time allocation
  • Demonstrating value to key stakeholders
  • Key performance indicators
  • Visit frequency for building and maintaining thought leader relationships

2. Field-Based Medical Team Staffing
  • Span of control and headcount
  • Reasons behind change in headcount

3. Field-Based Medical Team Training
  • Training standardization vs customization
  • Format and frequency

KEY METRICS

  • How many hours do your MSLs spend on the listed activities per week?
  • How would you rate the value associated with the listed field-based medical team responsibilities?
  • What is the effectiveness of listed qualitative and quantitative metrics in measuring the success of field-based medical teams?
  • What level of face-to-face visits from field-based medical team members do you expect in order to maintain old and develop new relationships with national and regional-level thought leaders (per year)?
  • Please provide the number of FTEs in your field-based medical team organization for each of the mentioned employee types
  • Please evaluate the importance of key factors that would cause you to increase the number of MSLs
  • Please evaluate the importance of key factors that would cause you to decrease the number of HOLs
  • Do you use a form of standardized training for all FBMT members regardless of region or therapeutic areas?
  • Do you provide customized training for any of the listed factors?
  • What is the frequency of MSL training on the listed areas?
  • How much time does your field-based medical team organization dedicate on training per year for the listed areas?

SAMPLE KEY FINDINGS

  • Value vs. Time Spent on Activities: There are areas that MSL and HOL teams should consider spending more time on because of the associated high value.
    • HOL teams have the opportunity to increase time allocation on KOL management and congress support/attendance: While 60% of participants find these activities very valuable, HOLs spend 5hrs. / week on KOL management and 2 hrs. / week on congress support/attendance.

METHODOLOGY


Best Practices, LLC engaged 14 Medical Affairs leaders from 12 companies focused on cardiovascular and metabolic therapeutic areas through a benchmarking survey instrument. Eighty-five percent of benchmark partners serve at the Senior Director level or above.


Industries Profiled:
Health Care; Pharmaceutical; Diagnostic; Manufacturing; Biotech; Consumer Products; Medical Device; Biopharmaceutical; Clinical Research; Laboratories


Companies Profiled:
Abbott; Abbvie; Bayer; Incyte; Kyowa Kirin; MSD; Novartis; Pfizer; Roche; Sanofi; UCB Pharma; ZS Pharma

If you purchase Best Practice Database document(s), you will have 30 days from the date of purchase to apply some or all of the cost of the document(s) toward the cost of a Full Access Individual, Pharma, Group or University Membership. Write us at DatabaseTeam@bestpracticesllc.com or call David Guinn at 919-767-9179 if you have any questions.